Overview
Dr Azza Attia is a distinguished clinical geneticist and genomic medicine leader with more than 24 years of national and international experience in clinical genetics and genomic medicine. With a strong academic and clinical background, she has built her career at the intersection of scientific excellence, patient care, and healthcare transformation.
As Head of Clinical Genomics at M42, Dr Azza plays a key role in advancing the integration of genomics into everyday clinical practice. Her work focuses on translating complex genomic science into meaningful clinical applications that support personalized, preventive, and precision-based care across the UAE and the wider region.
At the core of her professional philosophy is the belief that genomics delivers its greatest value when it moves beyond the laboratory and becomes part of real-world patient care. She strongly advocates for preventive medicine and believes genomic medicine can help shape more proactive and efficient healthcare systems.
Dr Azza is widely recognized for her contribution to solving complex clinical cases and supporting the implementation of large-scale genetic and genomic screening programs. Her work reflects a vision for healthcare that is more precise, predictive, and preventive while remaining grounded in evidence-based practice and measurable patient outcomes.
Known for her patient-centered and implementation-focused leadership style, Dr Azza represents a new generation of genomic medicine experts bridging advanced diagnostics with practical clinical decision-making.
Through her leadership, she continues to support the responsible adoption of genomic medicine, helping improve early diagnosis, patient outcomes, and the future of precision healthcare in the region.
